(Q51293206)

2 April 2018

title

Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer. (English)

1 reference

2 April 2018

1 reference

Seth Rummel

1

1 reference

2 April 2018

Erika Varner

series ordinal

2

1 reference

2 April 2018

Craig D Shriver

series ordinal

3

1 reference

2 April 2018

Rachel E Ellsworth

series ordinal

4

1 reference

2 April 2018

language of work or name

English

0 references

publication date

29 November 2012

1 reference

2 April 2018

Breast Cancer Research and Treatment

published in

1 reference

2 April 2018

volume

137

1 reference

2 April 2018

issue

1

1 reference

2 April 2018

page(s)

119-125

1 reference

2 April 2018

Triple-negative/basal-like breast cancer: review

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Triple negative breast cancer: unmet medical needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

BRCA1 regulates human mammary stem/progenitor cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

The basal phenotype of BRCA1-related breast cancer: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Genomic rearrangements in the BRCA1 and BRCA2 genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Evidence for a BRCA1 founder mutation in families of West African ancestry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Iniparib plus chemotherapy in metastatic triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

Prevalence and Predictors ofBRCA1andBRCA2Mutations in a Population-Based Study of Breast Cancer in White and Black American Women Ages 35 to 64 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2348-2

10.1007/S10549-012-2348-2

21 January 2018

Identifiers

DOI

1 reference

2 April 2018

1 reference

2 April 2018